{"id":10622,"date":"2019-10-28T18:51:27","date_gmt":"2019-10-28T17:51:27","guid":{"rendered":"https:\/\/udic.es\/?p=10622"},"modified":"2019-11-07T18:52:29","modified_gmt":"2019-11-07T17:52:29","slug":"our-parkinsons-and-alzheimers-research-unit","status":"publish","type":"post","link":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/","title":{"rendered":"Our Parkinson’s and Alzheimer’s research unit"},"content":{"rendered":"

– Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module from 5:30 hours). Completed during the LXX Annual Meeting of the Spanish Society of Neurology (Seville, 24 November 2018).<\/span><\/strong><\/p>\n

– Continue the development of our projects in Parkinson’s disease: anti-alfasinuclein monoclonal antibodies, gastric-retention levodopa, antidiscinetic drug in advanced Parkinson’s, new drug against hallucinations and delusions in Parkinson’s disease dementia.<\/span><\/strong> <\/span><\/strong><\/p>\n

– UDIC is performing several clinical trials in Alzheimer’s disease: oral drug acting like inhibitor of amyloid, anti-amyloid monoclonal antibodies (intravenously and subcutaneously), neuromodulator drug in moderated Alzheimer’s disease.<\/span><\/strong><\/p>\n

– Many patients still are taking part in a study in Progressive Supranuclear Paralysis with an anti-tau monoclonal antibodies.<\/span><\/strong><\/p>\n

 <\/p>\n

The Hospital Universitari General de Catalunya appoints Dr. Balaguer<\/strong> as the new Research Director on June 12, 2013.<\/p>\n

Drugs authorized in our country or approved by the FDA, which were evaluated by the UDIC<\/strong>: Rivastigmine (Exelon), Entacapone (Comtan), Rotigotine (Neupro), Pramipexol ER (Mirapexin LP), Ropinirol ER (Requip LP) Safinamide (Xadago) , Opicapona (Ongentys), Pimavanserin (Nuplazid), CVT 301 (..)<\/p>\n

Visit of Dr. Chris Kenney: The Medical Director of ACORDA, holder of CVT 301 (Levodopa inhaled) and Tozadenant came to our facilities during his visit to our country. The UDIC<\/strong> was a pioneer and main recruiter of patients in both clinical trials.<\/p>\n

Audits and Inspections:<\/span><\/h4>\n

Random inspection FDA: In 2009 our Unit got over unqualified a random inspection of Spanish centers that had participated in a clinical trial in Parkinson’s disease.<\/p>\n

The UDIC<\/strong> has passed frequent national and international audits, carried out in general due to its high rate of patient inclusion. During the year 2017, international audits of one trial in Parkinson’s disease and another in Alzheimer’s disease were developed, with satisfactory results.<\/p>\n

-Featured articles-<\/h4>\n

– Our Unit has been the first center in our country to start two new trials: antidiscinetic in phase II in Parkinson’s, and Alzheimer’s (muscarinic agonist, phase Ib).<\/p>\n

– We are the first center, with the largest number of patients included, in the new trial in Progressive Supranuclear Paralysis<\/p>\n

– First Spanish recruiting center in a trial with a new drug in Alzheimer’s.<\/p>\n

The prestigious scientific journal NATURE has published a Phase II trial with a monoclonal anti-amyloid antibody (aducanumab) in Alzheimer’s disease, with a positive result. The UDIC<\/strong> participates in the development of Phase III of this project, in the EMERGE trial.<\/p>\n

-Trial of Solanezumab for Mild Dementia Due to Alzheimer\u2019s Disease. <\/span><\/p>\n

Lawrence S.H onig, Bruno Vellas, Michael Woodward, Merc\u00e8 Boada et al.
\nN Engl J Med 2018; 378:321-330. January 25, 2018<\/p>\n

http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa1705971<\/a><\/p>\n

–Dr Balaguer<\/strong> en La Vanguardia.<\/p>\n

The scientific community continues to work in the search for solutions to Alzheimer’s. Researchers shed a light of hope at the negative result of the large clinical trial with solanezumab<\/p>\n

http:\/\/www.lavanguardia.com\/ciencia\/opinion\/20180125\/44283094017\/comunidad-cientifica-busqueda-soluciones-alzheimer-solanezumab.html<\/a><\/p>\n

-BAN-<\/strong><\/p>\n

http:\/\/eisai.mediaroom.com\/2018-07-25-Eisai-And-Biogen-Announce-Detailed-Results-Of-Phase-II-Clinical-Study-Of-BAN2401-In-Early-Alzheimers-Disease-At-Alzheimers-Association-International-Conference-AAIC-2018<\/a><\/p>\n

-Mission-<\/strong><\/p>\n

http:\/\/eisai.mediaroom.com\/2018-07-25-Eisai-And-Biogen-Present-Detailed-Results-From-Phase-II-Clinical-Study-Of-Elenbecestat-In-MCI-And-Mild-To-Moderate-Alzheimers-Disease-At-Alzheimers-Association-International-Conference-AAIC-2018<\/a><\/p>\n

-El peri\u00f3dico-<\/strong><\/p>\n

https:\/\/www.elperiodico.com\/es\/sociedad\/20180612\/el-hospital-general-participa-en-un-estudio-para-frenar-el-parkinson-6872323<\/a><\/p>\n

http:\/\/www.totsantcugat.cat\/actualitat\/societat\/balaguer-podriem-revertir-la-progressio-de-la-malaltia-de-parkinson-1_174858102.html<\/a><\/p>\n

\"\"<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

– Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module from 5:30 hours). Completed during the LXX Annual Meeting of the Spanish Society of Neurology (Seville, 24 November 2018). – Continue the development of our projects in Parkinson’s disease: anti-alfasinuclein monoclonal antibodies,…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[135],"tags":[],"class_list":["post-10622","post","type-post","status-publish","format-standard","hentry","category-news"],"yoast_head":"\nOur Parkinson's and Alzheimer's research unit - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica<\/title>\n<meta name=\"description\" content=\"- Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Our Parkinson's and Alzheimer's research unit - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"og:description\" content=\"- Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module\" \/>\n<meta property=\"og:url\" content=\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\" \/>\n<meta property=\"og:site_name\" content=\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-28T17:51:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-11-07T17:52:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/05222cf6c112313d8bd6302b1dd841db\"},\"headline\":\"Our Parkinson’s and Alzheimer’s research unit\",\"datePublished\":\"2019-10-28T17:51:27+00:00\",\"dateModified\":\"2019-11-07T17:52:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\"},\"wordCount\":507,\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\",\"url\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\",\"name\":\"Our Parkinson's and Alzheimer's research unit - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"isPartOf\":{\"@id\":\"https:\/\/udic.es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg\",\"datePublished\":\"2019-10-28T17:51:27+00:00\",\"dateModified\":\"2019-11-07T17:52:29+00:00\",\"description\":\"- Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module\",\"breadcrumb\":{\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/udic.es\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Our Parkinson’s and Alzheimer’s research unit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/udic.es\/#website\",\"url\":\"https:\/\/udic.es\/\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"description\":\"Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"publisher\":{\"@id\":\"https:\/\/udic.es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/udic.es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/udic.es\/#organization\",\"name\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\",\"url\":\"https:\/\/udic.es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"contentUrl\":\"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png\",\"width\":408,\"height\":123,\"caption\":\"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica\"},\"image\":{\"@id\":\"https:\/\/udic.es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/05222cf6c112313d8bd6302b1dd841db\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/udic.es\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/01b74981a1dc6465598570f8e716acf9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/01b74981a1dc6465598570f8e716acf9?s=96&d=mm&r=g\",\"caption\":\"admin\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Our Parkinson's and Alzheimer's research unit - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"- Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/","og_locale":"en_US","og_type":"article","og_title":"Our Parkinson's and Alzheimer's research unit - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","og_description":"- Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module","og_url":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/","og_site_name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","article_publisher":"https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci%c3%b3-Cl%c3%adnica-447149502490430\/","article_published_time":"2019-10-28T17:51:27+00:00","article_modified_time":"2019-11-07T17:52:29+00:00","og_image":[{"url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg","type":"","width":"","height":""}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#article","isPartOf":{"@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/"},"author":{"name":"admin","@id":"https:\/\/udic.es\/#\/schema\/person\/05222cf6c112313d8bd6302b1dd841db"},"headline":"Our Parkinson’s and Alzheimer’s research unit","datePublished":"2019-10-28T17:51:27+00:00","dateModified":"2019-11-07T17:52:29+00:00","mainEntityOfPage":{"@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/"},"wordCount":507,"publisher":{"@id":"https:\/\/udic.es\/#organization"},"image":{"@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/","url":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/","name":"Our Parkinson's and Alzheimer's research unit - UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","isPartOf":{"@id":"https:\/\/udic.es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage"},"image":{"@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage"},"thumbnailUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg","datePublished":"2019-10-28T17:51:27+00:00","dateModified":"2019-11-07T17:52:29+00:00","description":"- Dr. Balaguer, scientific director of the UDIC, has directed the course of Coordination and Practical Management of clinical trials in Neurology (module","breadcrumb":{"@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#primaryimage","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/11\/Proyectos1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/udic.es\/en\/our-parkinsons-and-alzheimers-research-unit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/udic.es\/en\/"},{"@type":"ListItem","position":2,"name":"Our Parkinson’s and Alzheimer’s research unit"}]},{"@type":"WebSite","@id":"https:\/\/udic.es\/#website","url":"https:\/\/udic.es\/","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","description":"Unitat D'Investigaci\u00f3 Cl\u00ednica","publisher":{"@id":"https:\/\/udic.es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/udic.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/udic.es\/#organization","name":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica","url":"https:\/\/udic.es\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/","url":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","contentUrl":"https:\/\/udic.es\/wp-content\/uploads\/2017\/08\/logo.png","width":408,"height":123,"caption":"UDIC Unitat D'Investigaci\u00f3 Cl\u00ednica"},"image":{"@id":"https:\/\/udic.es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/UDIC-Unitat-dInvestigaci\u00f3-Cl\u00ednica-447149502490430\/"]},{"@type":"Person","@id":"https:\/\/udic.es\/#\/schema\/person\/05222cf6c112313d8bd6302b1dd841db","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/udic.es\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/01b74981a1dc6465598570f8e716acf9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/01b74981a1dc6465598570f8e716acf9?s=96&d=mm&r=g","caption":"admin"}}]}},"_links":{"self":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/10622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/comments?post=10622"}],"version-history":[{"count":0,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/posts\/10622\/revisions"}],"wp:attachment":[{"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/media?parent=10622"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/categories?post=10622"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/udic.es\/en\/wp-json\/wp\/v2\/tags?post=10622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}